ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 9

Integration of Cytokine Profiles with Distinct B-Cell Functions Reveals a Specific Micro-Environmental Framework in Autoimmune Diseases

Quentin Simon1, Alexis Grasseau2, Bénédicte Rouvière2, Laetitia Le Pottier2, Divi Cornec3, Maria Orietta Borghi4, Rocio Aguilar Quesada5, Yves Renaudineau2,6, Marta Alarcón-Riquelme7, Jacques-Olivier Pers1 and Sophie Hillion2,6, 1U1227, Université de Brest, Inserm, Labex IGO, CHU de Brest, Brest, France, 2U1227, Lymphocytes B et Autoimmunité, Université de Brest, Inserm, Brest, France, 3Hopital La Cavale Blanche, Brest, France, 4University of Milan, IRCCS Istituto Auxologico Italiano, Milan, Italy, 5Biobanco Del Sistema Sanitario Publico de Andalucía, Sevilla, Spain, 6CHU de Brest, Brest, France, 7Medical Genomics, Center for Genomics and Oncological Research (GENYO), Granada, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: autoimmune diseases, B cells, cytokines and environmental factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The functional duality of B cells is central to balance immune homeostasis by regulating or promoting the immune response. However, the mechanisms by which the cytokine environment is involved in B-cell fate decisions leading to distinct B-cell functions are largely unknown.

Methods: We designed an in vitro approach to understand how extracellular components participate in human B-cell functional plasticity, and how this network might be involved in autoimmune diseases. Two activated T cell subsets (CD4+CD45RA+ (TRA) and CD4+CD45RO+ (TRO) T cells) were used to expose a common pool of B cells to distinct microenvironments. We showed that the same B-cell population could experience two possible opposite evolutions, to either helper or suppressor functions, in a flexible manner. These cells were thus referred to as effector B cells (Eff B) or suppressor B cells (Supp B). We analyzed the nature of those distinct bystander signals to assess the different functional cytokine clusters linked to phenotypic changes in B cells and explored the influence of those cytokine patterns in 179 Patients with systemic autoimmune diseases (SADs) and 48 healthy volonteers included in the PRECISESADS project [RA (n=44), SLE (n=45), systemic sclerosis (n=46), and Sjogren’s syndrome (SjS, n=44]).

Results: We showed that distinct cytokine modules were involved in the modulation of B-cell functions. The identification of functional cytokine modules showed that the suppressive function of B cells was associated with Th2-related cytokines (IL-13, IL-5, IL-9 and IL-10) while the effector module, headed by IL-6 and CXCL10, also included CXCL1 and IL-8. Finally, we observed a common last cluster of cytokines that we considered to be a master modulator group able to control each cytokine network. This module included TNF-α, IFN-γ, IL-2 and IL-21. The key players of the effector module consisting of IL-6 and CXCL10 were over-represented in the four SADs, underlining a common key pathogenic cytokine network. We then wanted to address whether the analysis of the two different clusters of patients could be linked to biological activities and/or clinical manifestations. The measure of anti-nuclear antigen autoAb in patients delimited a more autoreactive pattern in the disconnected SLE patients cluster, demonstrating a significant increase in anti-DNA Ab and anti-SSA-52KD Ab. We, next confirmed a selective increase in systemic autoreactivity in disconnected SjS patients cluster with the upregulation of anti-SSB Ab and the increase of rheumatoid factors in disconnected RA patients. Finally, we underlined a major increase of extra-glandular clinical manifestations in the disconnected SjS patients group depicting a strong systemic activity of the disease. We also observed in SLE patients that the appearance of clinical symptoms of nephritic disorders during the course of the disease was significantly higher in the disconnected cluster.

Conclusion: Our experimental and translational approach identified subgroups of SADs patients, particularly distinguished by an effector B-cell signature.

Support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking PRECISESADS grant n° 115565


Disclosure: Q. Simon, EFPIA, 2; A. Grasseau, EFPIA, 2; B. Rouvière, EFPIA, 2; L. Le Pottier, EFPIA, 2; D. Cornec, None; M. O. Borghi, EFPIA, 2; R. Aguilar Quesada, EFPIA, 2; Y. Renaudineau, EFPIA, 2; M. Alarcón-Riquelme, Sanofi, Bayer, UCB, Eli Lilly and Servier, 2; J. O. Pers, EFPIA, 2; S. Hillion, EFPIA, 2.

To cite this abstract in AMA style:

Simon Q, Grasseau A, Rouvière B, Le Pottier L, Cornec D, Borghi MO, Aguilar Quesada R, Renaudineau Y, Alarcón-Riquelme M, Pers JO, Hillion S. Integration of Cytokine Profiles with Distinct B-Cell Functions Reveals a Specific Micro-Environmental Framework in Autoimmune Diseases [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/integration-of-cytokine-profiles-with-distinct-b-cell-functions-reveals-a-specific-micro-environmental-framework-in-autoimmune-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/integration-of-cytokine-profiles-with-distinct-b-cell-functions-reveals-a-specific-micro-environmental-framework-in-autoimmune-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology